LEAMINGTON,
Ontario, March 17, 2022 – PRESS RELEASE – Tilray Brands Inc., a leading
global cannabis-lifestyle and consumer packaged goods company focused on
inspiring and empowering the worldwide community to live their very best life, announced
that its medical cannabis division, Tilray Medical, has expanded its medical
cannabis offering and launched the first EU GMP-certified medical cannabis oil
products in Malta. Tilray’s EU-GMP medical cannabis products are now available
in pharmacies across Malta, providing patients with safe and reliable access to
high-quality medical cannabis.
Denise
Faltischek, Tilray’s chief strategy officer and head of international business,
said, “Demand for medical cannabis in Malta is growing rapidly and we are
incredibly proud to service patients with the high-quality medical cannabis
products they rely on and in the formats they prefer.”
In
Malta, patients may obtain prescriptions for medical cannabis and a medical
cannabis card through family doctors. Medical cannabis cards are issued by
Malta’s superintendent of Public Health.
Tilray
has a pioneering track record as a company committed to making EU
GMP-certified, pharmaceutical-grade medical cannabis products available to
patients in need around the world and was the first to successfully export
medical cannabis from North America and import medical cannabis products into
the EU in 2016.
